** Shares of IDT Australia RIC rise 8.9% to A$0.098; marks biggest intraday percentage gain since January 28
** The pharma manufacturer secures manufacturing contract with Nacuity Pharmaceuticals Pty for NPI-001, an investigational treatment for retinitis pigmentosa
** Five-year contract with initial A$3.2 million ($1.91 million) work expected to complete by FY2026, adds co
** Stock down 18.2% this year, as of last close
($1 = 1.6753 Australian dollars)
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.